Dupont Capital Management’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-94,979
| Closed | -$16.8M | – | 1471 |
|
|
2020
Q1 | $16.8M | Buy |
94,979
+63,067
| +198% | +$11.9M | 0.4% | 39 |
|
|
2019
Q4 | $6.1M | Buy |
31,912
+3,551
| +13% | +$641K | 0.14% | 127 |
|
|
2019
Q3 | $4.77M | Buy |
28,361
+23,478
| +481% | +$3.83M | 0.11% | 153 |
|
|
2019
Q2 | $818K | Hold |
4,883
| – | – | 0.02% | 602 |
|
|
2019
Q1 | $715K | Buy |
4,883
+600
| +14% | +$87K | 0.02% | 635 |
|
|
2018
Q4 | $572K | Buy |
4,283
+970
| +29% | +$159K | 0.01% | 689 |
|
|
2018
Q3 | $631K | Sell |
3,313
-446
| -12% | -$81.9K | 0.01% | 677 |
|
|
2018
Q2 | $627K | Buy |
3,759
+1,487
| +65% | +$239K | 0.01% | 655 |
|
|
2018
Q1 | $382K | Sell |
2,272
-10,995
| -83% | -$1.84M | 0.01% | 721 |
|
|
2017
Q4 | $2.17M | Sell |
13,267
-72,008
| -84% | -$12.9M | 0.05% | 333 |
|
|
2017
Q3 | $17.5M | Buy |
85,275
+2,809
| +3% | +$653K | 0.4% | 43 |
|
|
2017
Q2 | $20M | Buy |
82,466
+15,051
| +22% | +$3.54M | 0.45% | 37 |
|
|
2017
Q1 | $16.1M | Buy |
67,415
+2,352
| +4% | +$548K | 0.36% | 44 |
|
|
2016
Q4 | $13.7M | Sell |
65,063
-35,089
| -35% | -$7.27M | 0.31% | 61 |
|
|
2016
Q3 | $23.1M | Buy |
100,152
+15,094
| +18% | +$3.69M | 0.52% | 24 |
|
|
2016
Q2 | $19.7M | Sell |
85,058
-10,230
| -11% | -$2.36M | 0.44% | 38 |
|
|
2016
Q1 | $25.5M | Buy |
95,288
+7,538
| +9% | +$2.16M | 0.58% | 27 |
|
|
2015
Q4 | $27.4M | Sell |
87,750
-3,207
| -4% | -$955K | 0.66% | 20 |
|
|
2015
Q3 | $24.7M | Sell |
90,957
-43,553
| -32% | -$13.4M | 0.62% | 28 |
|
|
2015
Q2 | $40.8M | Buy |
134,510
+32,491
| +32% | +$9.69M | 0.88% | 19 |
|
|
2015
Q1 | $30.4M | Buy |
102,019
+99,208
| +3,529% | +$28.3M | 0.6% | 37 |
|
|
2014
Q4 | $724K | Sell |
2,811
-1,901
| -40% | -$475K | 0.01% | 515 |
|
|
2014
Q3 | $1.14M | Sell |
4,712
-16,042
| -77% | -$3.59M | 0.02% | 434 |
|
|
2014
Q2 | $4.63M | Buy |
20,754
+5,452
| +36% | +$1.13M | 0.08% | 209 |
|
|
2014
Q1 | $3.15M | Buy |
15,302
+5,394
| +54% | +$1.07M | 0.05% | 280 |
|
|
2013
Q4 | $1.67M | Sell |
9,908
-4,996
| -34% | -$781K | 0.03% | 400 |
|
|
2013
Q3 | $2.15M | Hold |
14,904
| – | – | 0.04% | 358 |
|
|
2013
Q2 | $1.88M | Buy |
+14,904
| New | +$1.69M | 0.04% | 384 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Dupont Capital Management's AGN Position: Q2 2020 in Review
Dupont Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 94,979 shares — an estimated $16.8M sold.
Dupont Capital Management first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $40.8M in Q2 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Dupont Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Dupont Capital Management sold 94,979 Allergan plc shares in Q2 2020, an estimated $16.8M.
- Dupont Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
- Dupont Capital Management's Allergan plc position peaked at $40.8M in Q2 2015.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Dupont Capital Management's 13F filing for Q2 2020, filed 24 Jul 2020.